SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ziopharm -- Ignore unavailable to you. Want to Upgrade?


To: PLegee who wrote (13)11/7/2017 9:17:23 AM
From: The Ox  Respond to of 14
 
finance.yahoo.com
  • Pivotal, randomized control trial in rGBM to initiate by end of 2017
  • Combination trial with checkpoint inhibitor in rGBM to initiate by end of 2017
  • Point-of-care trial with CAR+ T cells co-expressing membrane-bound interleukin (mbIL15) to initiate in 2018